Cargando…
Baseline risk of recurrence in stage I–II endometrial carcinoma
OBJECTIVE: Though there are no evidences that postoperative therapy improves overall survival (OS) in stage I–II endometrial carcinoma, many women receive postoperative radiation or chemotherapy. This study aimed to investigate the baseline risk of recurrence after complete resection without any adj...
Autores principales: | Sasada, Shinsuke, Yunokawa, Mayu, Takehara, Yae, Ishikawa, Mitsuya, Ikeda, Shunichi, Kato, Tomoyasu, Tamura, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709535/ https://www.ncbi.nlm.nih.gov/pubmed/29185267 http://dx.doi.org/10.3802/jgo.2018.29.e9 |
Ejemplares similares
-
A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma
por: Takahashi, Kenta, et al.
Publicado: (2018) -
The baseline recurrence risk of patients with intermediate-risk cervical cancer
por: Yoneoka, Yutaka, et al.
Publicado: (2021) -
Brain Metastases from Uterine Cervical and Endometrial Cancer
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021) -
Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
por: Kato, Mayumi Kobayashi, et al.
Publicado: (2021) -
Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers
por: Shimoi, Tatsunori, et al.
Publicado: (2021)